Karuna Kanagaratnam

Dendreon: I Want the Truth

Andrew,

I have disclosed on my other Dendreon articles that I am LONG(an unhealthy amount) on the stock. This one was emailed directly to the editor and my position was not disclosed.

I have enjoyed your last article on DNDN with the slide from Dr. Nicole Provost's presentation.

We have seen Eli Lilly get Gemzar approved behind closed doors after panel voted against it 9-2 last year. FDA was mum on the decision. My concern though is that DNDN lack the experience, political clout, and savvy to pull this off. FDA's CR letter seems to be an invitation to do just that. The point being FDA didn't shut the door. I think that any of the BIG PHARMA's with a similar situation would quietly work behind the scenes and to quote, Larry the Cable Guy, "Get her done".

I think Dendreon has terrific and wonderful scientists who are not as business savvy. That is a difficult task as you must, "Swim with the Sharks without being Eaten Alive". We have also seen guffaws from simple press release of layoff's turned into a reporter(Dan Richman of Seattle PI-who I spoke to and he quoted me as saying that delay could kill Dendreon) quoting DNDN as saying that, "Provenge won't be ready until 2009 at the earliest." He relented and printed a retraction from share holders contacting him directly and challenging the quote.

Biotech Stock Research Letter today says, that the only hope is through congressional hearings.
The COMPANY is not capable of pulling this off. It must come from its supporters, patient advocacy groups, etc.

I think you can help along with your clients by contacting your congressman, etc. That is what I am doing.

This is worth watching (takes a couple of minutes to load) www.channel4.com/playe...

Have to click play after commercial. Ironic, US build walls and China tears down theirs…

Through out history the establishment has stood in the way of progress. I think in time these technologies will find their way...Unfortunately, many who need it now won't be here...